Global biopharmaceutical and biomedicine market || keyplayers Novartics AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A

Global biopharmaceutical and biomedicine market is expected to register lucrative growth over the forecast period. Increasing number of product approvals, coupled with increasing R&D investments by manufacturers are major factors expected to propel growth of the target market over the forecast period.

In recent years, U.S. and Europe’s regulatory bodies have approved number of biopharmaceutical products, which have been launched in market. For instance, Sanofi S.A. received FDA approval for Admelog for blood sugar level management.

Furthermore, the companies are also involved in strategic acquisition and collaboration, which is also expected to drive the market in the near future. For instance, In March 2018, Wuxi Biologics Co. Ltd. Collaborated with Adagene Inc., for the research and development of a novel antibody therapeutics.

The global biopharmaceutical and biomedicine market is segmented on the basis of product type, application, and region.

On the basis of product type, the global market is segmented into biopharmaceutical, nanomedicine, cell & gene therapy, bioinformatics, and molecular enzymes & kits. The biopharmaceutical segment is further sub-segmented based on monoclonal antibodies, vaccines, human growth hormone, recombinant human insulin, interferon, erythropoietin, colony stimulating factor, fusion protein, blood factors, and others. The biopharmaceutical segment accounted for major revenue share in 2018.

On the basis of application, the global market is segmented into therapeutics, diagnostics, and research and development. The therapeutics segment accounted for highest revenue share and is expected to maintain its dominance over the forecast period.

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The biopharmaceutical and biomedicine market in North America accounted for highest revenue share, in 2018 and is expected to maintain its dominance over the forecast period. Increasing presence well–established healthcare infrastructure and high adoption of advanced technologies for manufacturing drugs are major factors expected to support growth of the target market in the region over the forecast period.

Key players operating in the global biopharmaceutical and biomedicine market includes Novartics AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A., Eli Lilly and Company, Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb, Qiagen N.V., Affimed N.V., and Celgene Corporation.

Contact Us:
Mr Alex (Sales Manager)
Prophecy Market Insights
Phone: +91 777 504 9802
+1 860 531 2701
Email: sales@prophecymarketinsights.com

About us:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

This release was published on openPR.